Historical hallmarks of anticoagulation and antiplatelet agents
Ημερομηνία
2016Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Thrombosis is a well known phenomenon among physicians since antiquity. A variety of peculiar agents, such as leeches and bark, were used to prevent it. Hirudin was used during the 19th century. The next eon, heparin, strepokinase, urokinase, TPA, dicumarol, warfarin, aspirin, ticlopidine, Clopidogrel, SSHA and SP54 provoked huge advances in anticoagulation. During 21st century with the use of fondaparinux, dabigatran, rivaroxaban and Ticagrelor antithrombotic prevention and therapeutic interaction entered an era of medical challenges. Although the risk after a thrombotic episode is now highly reduced, blood clots still present damaging or even lethal consequences in human organisms and further research is strongly recommended. © 2016 Bentham Science Publishers.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Antithrombotic therapy for elderly patients with acute coronary syndrome: Reasons to be cautious
Kotsiou O.S., Xirogiannis I.K. (2020)[No abstract available] -
Patterns in the management of superficial vein thrombosis
Karathanos C., Spanos K., Lachanas V., Athanasoulas A., Giannoukas A.D. (2017)Objective: To highlight current practice patterns in management of superficial vein thrombosis. Methods: An electronic survey was conducted using the mailing lists of the Mediterranean League of Angiology and Vascular ... -
Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis
Ntaios G., Papavasileiou V., Sagris D., Makaritsis K., Vemmos K., Steiner T., Michel P. (2018)Background and Purpose: Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ovale (PFO) closure versus medical treatment in patients with cryptogenic stroke or transient ischemic ...